SMO and Hepatic fibrosis: miR-378a-3p could suppresses activation of hepatic stellate cells by targeting Gli3 and its expression is regulated by Smo-dependent NF-ΚB signaling, suggesting miR-378a-3p has therapeutic potential for liver fibrosis [35].